Published in Neuro Oncol on May 18, 2016
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care (1993) 27.05
The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care (1994) 19.87
Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol (1998) 9.89
A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health (1980) 6.29
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
The 15D instrument of health-related quality of life: properties and applications. Ann Med (2001) 3.31
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol (2015) 3.21
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res (1996) 2.76
Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One (2014) 2.75
Cognitive deficits in adult patients with brain tumours. Lancet Neurol (2004) 2.71
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol (2009) 2.35
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol (2003) 2.00
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol (2003) 1.92
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer (2010) 1.84
EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy (1991) 1.74
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol (2003) 1.64
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res (2012) 1.62
Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg (1989) 1.46
Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol (1995) 1.45
Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer (1998) 1.30
Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry (2003) 1.30
Review on quality of life issues in patients with primary brain tumors. Oncologist (2010) 1.24
Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer (2002) 1.18
Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol (2009) 1.16
Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. J Pain Symptom Manage (2010) 1.15
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival. Neuro Oncol (2013) 1.14
Compromised health-related quality of life in patients with low-grade glioma. J Clin Oncol (2011) 1.08
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol (2011) 1.06
Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology (2001) 1.02
The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer (2006) 1.00
Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol (2003) 1.00
Seizures and the natural history of World Health Organization Grade II gliomas: a review. Neurosurgery (2011) 1.00
Quality of life in patients with intracranial gliomas: the impact of modern image-guided surgery. J Neurosurg (2011) 0.99
Patient-centred healthcare outcome measures: towards a unified architecture. J R Soc Med (2014) 0.98
Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol (2007) 0.97
The "onco-functional balance" in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life. Acta Neurochir (Wien) (2013) 0.95
Quality of life in low-grade glioma patients receiving temozolomide. Neuro Oncol (2008) 0.95
Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neurooncol (2009) 0.87
The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review. Eur J Cancer (2014) 0.85
Health-related quality of life in stable, long-term survivors of low-grade glioma. J Clin Oncol (2015) 0.84
Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J Neurooncol (2011) 0.83
Health-related quality of life after TBI: a systematic review of study design, instruments, measurement properties, and outcome. Popul Health Metr (2015) 0.83
Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy. J Neurooncol (2010) 0.82
Surgical strategies in low-grade gliomas and implications for long-term quality of life. J Clin Neurosci (2014) 0.82
[French brain tumor database: general results on 40,000 cases, main current applications and future prospects]. Neurochirurgie (2012) 0.81
Proton therapy for low-grade gliomas: Results from a prospective trial. Cancer (2015) 0.81
Prospective assessment of health-related quality of life in patients with low-grade glioma: a single-center experience. Support Care Cancer (2011) 0.80
Quality of life and neuropsychological functions in long-term low-grade glioma survivors. Int J Radiat Oncol Biol Phys (1994) 0.78
Subjective quality of life in persons with low-grade glioma and their next of kin. Int J Rehabil Res (2009) 0.78
Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials. Neurooncol Pract (2015) 0.76
[Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas]. Wien Med Wochenschr (2011) 0.76
Health-related quality of life aspects in patients with low-grade glioma. Adv Tech Stand Neurosurg (2010) 0.76
Hemiparesis after Operation of Astrocytoma Grade II in Adults: Effects of Acupuncture on Sensory-Motor Behavior and Quality of Life. Evid Based Complement Alternat Med (2013) 0.76